Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR-T cell combination therapy: the next revolution in cancer treatment
Maysoon Al‐Haideri, Santalia Banne Tondok, Salar Hozhabri Safa, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Recent advances in non-small cell lung cancer targeted therapy; an update review
Mahmood Araghi, Reza Mannani, Ali Heidarnejad maleki, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 122
Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 73
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 41
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 25
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 21
The dilemmas and possible solutions for CAR-T cell therapy application in solid tumors
Lihong Wang, Lufang Zhang, Louisa Chard Dunmall, et al.
Cancer Letters (2024) Vol. 591, pp. 216871-216871
Open Access | Times Cited: 17
Beyond the Barrier: Unraveling the Mechanisms of Immunotherapy Resistance
Hannah N. Bell, Weiping Zou
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 521-550
Closed Access | Times Cited: 15
Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
Shan Muhammad, Tao Fan, Yang Hai, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 38
CAR-T Cell Therapy: From the Shop to Cancer Therapy
Ashanti Concepción Uscanga‐Palomeque, Chavez-Escamilla Ana Karina, Cynthia Aracely Alvizo-Báez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15688-15688
Open Access | Times Cited: 29
T cell-derived exosomes in tumor immune modulation and immunotherapy
Qiujun Zhou, Shenyu Wei, Hui Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment
Yufeng Wang, David L. Drum, Ruochuan Sun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression
Walison da Silva, Pedro Augusto Carvalho Costa, Sérgio Ricardo Scalzo Júnior, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2655-2673
Open Access | Times Cited: 11
Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy
Rose Ghemrawi, Lama Abuamer, Sedra Kremesh, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2158-2158
Open Access | Times Cited: 8
Immunotherapy for Prostate Cancer: A Current Systematic Review and Patient Centric Perspectives
Laeeq ur Rehman, Muhammad Hassan Nisar, Wajeeha Fatima, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1446-1446
Open Access | Times Cited: 19
Recent Advances in Cancer Immunotherapy Delivery Modalities
Palaniyandi Muthukutty, Hyun Young Woo, Murali Ragothaman, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 504-504
Open Access | Times Cited: 18
CAR-T cell therapy for hematological malignancies: History, status and promise
Chao Wang, Jianpeng Wang, Shusheng Che, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21776-e21776
Open Access | Times Cited: 16
CAR-T Cell Therapy in Ovarian Cancer: Where Are We Now?
Clare Cutri‐French, Dimitrios Nasioudis, Erin George, et al.
Diagnostics (2024) Vol. 14, Iss. 8, pp. 819-819
Open Access | Times Cited: 6
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 6
Immunotherapy Study on Non-small-Cell Lung Cancer (NSCLC) Combined with Cytotoxic T Cells and miRNA34a
Richa Pandey, Chien‐Chih Chiu, Li‐Fang Wang
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1364-1381
Open Access | Times Cited: 5
Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress
Shigao Cheng, Huiyuan Wang, Xuejia Kang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 251-251
Open Access | Times Cited: 5
The role of viruses in cancer progression versus cancer treatment: A dual paradigm
Somya Ranjan Dash, Anushka Kundu, Chanakya Nath Kundu
Life Sciences (2024) Vol. 341, pp. 122506-122506
Closed Access | Times Cited: 5
Next-generation cancer vaccines and emerging immunotherapy combinations
Anne Brandenburg, Annkristin Heine, Peter Brossart
Trends in cancer (2024) Vol. 10, Iss. 8, pp. 749-769
Closed Access | Times Cited: 5
Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
Amirata Mohseni, Fatemeh Salehi, Samaneh Rostami, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
The role of hospital pharmacists in supporting the appropriate and safe use of CGT/ATMPs: a scoping review of current insights
Junnan Shi, Xianwen Chen, Hao Hu, et al.
BMC Health Services Research (2025) Vol. 25, Iss. 1
Open Access
Harnessing IL-27: challenges and potential in cancer immunotherapy
Ali Heidarnejad maleki, Mansour Rajabivahid, Elnaz Khosh, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top